These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32005264)

  • 21. Diagnostic Performance of the HCV Core Antigen Test To Identify Hepatitis C in HIV-Infected Patients: a Systematic Review and Meta-Analysis.
    Sepúlveda-Crespo D; Treviño-Nakoura A; Bellon JM; Jiménez-Sousa MA; Ryan P; Martínez I; Fernández-Rodríguez A; Resino S
    J Clin Microbiol; 2023 Jan; 61(1):e0133122. PubMed ID: 36537787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C Virus Screening: A Review of the OraQuick Hepatitis C Virus Rapid Antibody Test.
    D'Angelo RG; Klepser M; Woodfield R; Patel H
    J Pharm Technol; 2015 Feb; 31(1):13-19. PubMed ID: 34860920
    [No Abstract]   [Full Text] [Related]  

  • 23. Down-Classification of Hepatitis C Virus Diagnostics: Implications for Screening and Diagnosis.
    Terrault N
    J Infect Dis; 2024 May; 229(Supplement_3):S322-S327. PubMed ID: 37739784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid hepatitis C testing among persons at increased risk for infection--Wisconsin, 2012-2013.
    Stockman LJ; Guilfoye SM; Benoit AL; Vergeront JM; Davis JP;
    MMWR Morb Mortal Wkly Rep; 2014 Apr; 63(14):309-11. PubMed ID: 24717818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea.
    Lee JS; Choi HJ; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2479-2485. PubMed ID: 33788314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of true point of care molecular assay using fingerstick capillary whole blood for diagnosis of hepatitis C infection.
    Agarwal R; Gupta E; Kumar G; Singh KK; Sharma MK
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33704042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance Evaluation of
    Murayama A; Momose H; Yamada N; Matsubayashi K; Muramatsu M; Hamaguchi I; Kato T
    Front Cell Infect Microbiol; 2021; 11():793472. PubMed ID: 35186779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid point-of-care (POC) testing for Hepatitis C antibodies in a very high prevalence setting: persons injecting drugs in Tallinn, Estonia.
    Uusküla A; Talu A; Rannap J; Barnes DM; Jarlais DD
    Harm Reduct J; 2021 Apr; 18(1):39. PubMed ID: 33794927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver health events: an indigenous community-led model to enhance HCV screening and linkage to care.
    Pandey M; Konrad S; Reed N; Ahenakew V; Isbister P; Isbister T; Gallagher L; Campbell T; Skinner S
    Health Promot Int; 2022 Feb; 37(1):. PubMed ID: 34125199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of OraQuick HCV Rapid Antibody Test in Postmortem Specimens.
    Rose CE; Duncan L; Hawes AM
    Acad Forensic Pathol; 2020 Jun; 10(2):81-86. PubMed ID: 33282041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Universal Screening for Hepatitis C Virus in the ED Using a Best Practice Advisory.
    Ford JS; Chechi T; Toosi K; Mahmood B; Meehleis D; Otmar M; Tran N; May L
    West J Emerg Med; 2021 May; 22(3):719-725. PubMed ID: 34125052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Easy-to-Implement Risk Score for Targeted Hepatitis C Virus Testing in the General Population.
    Martínez-Sanz J; Vivancos-Gallego MJ; Fernández-Felix BM; Muriel A; Pérez-Elías P; Uranga A; Romero B; Galán JC; Moreno S; Pérez-Elías MJ
    Microbiol Spectr; 2022 Apr; 10(2):e0228621. PubMed ID: 35357241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using Preventive Health Alerts in the Electronic Health Record Improves Hepatitis C Virus Testing Among Infants Perinatally Exposed to Hepatitis C.
    Hojat LS; Greco PJ; Bhardwaj A; Bar-Shain D; Abughali N
    Pediatr Infect Dis J; 2020 Oct; 39(10):920-924. PubMed ID: 32453202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-life validation of a sample pooling strategy for screening of hepatitis C.
    Aguilera A; Fuentes A; Cea M; Carracedo R; Viñuela L; Ordóñez P; López-Fabal F; Sáez E; Cebrián R; Pérez-Revilla A; Pereira S; De Salazar A; García F
    Clin Microbiol Infect; 2023 Jan; 29(1):112.e1-112.e4. PubMed ID: 36210627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serologic versus molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies.
    Torres HA; Angelidakis G; Jiang Y; Economides M; Mustafayev K; Yibirin M; Orlowski R; Champlin R; Verstovsek S; Raad I
    Medicine (Baltimore); 2022 Sep; 101(37):e30608. PubMed ID: 36123927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Find the Missing Millions: Malaysia's experience with nationwide hepatitis C screening campaign in the general population.
    Md Said R; Mohd Zain R; Chan HK; Soelar SA; Rusli N; Nasir NH; Zakaria R; Hassan MRA
    J Viral Hepat; 2020 Jun; 27(6):638-643. PubMed ID: 31997563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What Hepatitis C Virus (HCV) Diagnostic Tools Are Needed to Advance Diagnosis of Current HCV Infection in Outreach Settings and in a Nonclinical Setting?
    Page K; Feinberg J
    J Infect Dis; 2024 May; 229(Supplement_3):S328-S333. PubMed ID: 37739782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Practicability of the Xpert HCV Viral Load Fingerstick Point-of-Care Assay in Primary Care Settings.
    Petroff D; Bätz O; Jedrysiak K; Kramer J; Berg T; Wiegand J
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of hepatitis C risk to hepatitis C test acceptance among adult patients participating in an ED hepatitis C screening programme.
    Cowan E; Brandspiegel S; Araki B; O'Brien-Lambert C; Merchant R; Buckler DG; Eiting E; Calderon Y
    Emerg Med J; 2023 May; 40(5):341-346. PubMed ID: 36593093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usability and acceptability of self-testing for hepatitis C virus infection among the general population in the Nile Delta region of Egypt.
    Reipold EI; Farahat A; Elbeeh A; Soliman R; Aza EB; Jamil MS; Johnson CC; Shiha G; Easterbrook P
    BMC Public Health; 2021 Jun; 21(1):1188. PubMed ID: 34158006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.